We are live on ! Find out more
LABP

Landos Biopharma, Inc. Common Stock
LABP

Delisted

LABP was delisted on the 23rd of May, 2024.

Back to rankings

47 hedge funds and large institutions have $219M invested in Landos Biopharma, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$194M
2
RI
RTW Investments
New York
+$55.8M
3
LGM
Logos Global Management
California
+$9.58M
4
O
OrbiMed
New York
+$8.89M
5
DM
Deerfield Management
New York
+$5.87M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$141M +$194M +1,486,992 New
RI
2
RTW Investments
New York
$38.3M +$55.8M +427,572 New
LGM
3
Logos Global Management
California
$7.07M +$9.58M +73,400 New
O
4
OrbiMed
New York
$6.56M +$8.89M +68,100 New
DM
5
Deerfield Management
New York
$4.33M +$5.87M +45,000 New
JP Morgan Chase
6
JP Morgan Chase
New York
$3.61M +$4.89M +37,502 New
BlackRock
7
BlackRock
New York
$2.47M +$3.34M +25,629 New
WP
8
Woodline Partners
California
$2.05M +$2.78M +21,334 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.81M +$2.46M +18,846 New
Macquarie Group
10
Macquarie Group
Australia
$1.42M +$1.92M +14,718 New
Ensign Peak Advisors
11
Ensign Peak Advisors
Utah
$1.2M +$1.63M +12,500 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.06M +$1.44M +11,056 New
AI
13
ArchPoint Investors
Florida
$939K +$1.27M +9,748 New
MIM
14
Monashee Investment Management
Massachusetts
$879K +$1.19M +9,131 New
ZP
15
Zimmer Partners
New York
$868K +$1.18M +9,010 New
Northern Trust
16
Northern Trust
Illinois
$716K +$970K +7,436 New
SFM
17
Sphera Funds Management
Israel
$674K +$913K +7,000 New
Tudor Investment Corp
18
Tudor Investment Corp
Connecticut
$596K +$808K +6,190 New
DKCM
19
Davidson Kempner Capital Management
New York
$480K +$652K +5,000 New
State Street
20
State Street
Massachusetts
$473K +$641K +4,910 New
CCM
21
CAAS Capital Management
New York
$385K +$522K +4,000 New
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
$348K +$472K +3,614 New
Two Sigma Investments
23
Two Sigma Investments
New York
$233K +$315K +2,415 New
Bank of America
24
Bank of America
North Carolina
$193K +$260K +1,995 New
OWP
25
Old Well Partners
North Carolina
$176K +$239K +1,832 New
1
2

LABP Hedge Fund Activity: Q1 2021 in Review

47 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Landos Biopharma, Inc. Common Stock (LABP) for Q1 2021, worth a combined $219M.

Buyers outnumbered sellers: 47 funds opened new LABP positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $194M.

  • 47 institutional investors held Landos Biopharma, Inc. Common Stock (LABP) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $219M of Landos Biopharma, Inc. Common Stock stock for Q1 2021.
  • 47 funds opened new Landos Biopharma, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +47 holders.
  • The largest Landos Biopharma, Inc. Common Stock buyer in Q1 2021 was Perceptive Advisors, an estimated $194M added.

Based on aggregated 13F filings for Q1 2021.